ArticleNeoplasia (New York, N.Y.)2022

Combined radio-immunotherapy: An opportunity to increase the therapeutic ratio of oligometastasis-directed radiotherapy.

William Tyler Turchan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.